Detection of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive Aspergillosis

Autor: Lawrence N. Amankwa, Jeffrey D. Fuller, Linda J. Pinto, Margo M. Moore, Cassandra S. Carroll
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Siderophore
Carboxylic Acids
Siderophores
lcsh:Medicine
Artificial Gene Amplification and Extension
Hydroxamic Acids
Aspergillosis
Pathology and Laboratory Medicine
Ferric Compounds
Polymerase Chain Reaction
Aspergillus fumigatus
chemistry.chemical_compound
Liquid chromatography–mass spectrometry
Medicine and Health Sciences
lcsh:Science
Fungal Pathogens
Multidisciplinary
medicine.diagnostic_test
biology
Organic Compounds
Fungal Diseases
3. Good health
Chemistry
Infectious Diseases
Aspergillus
Aspergillus Fumigatus
Medical Microbiology
Physical Sciences
Biomarker (medicine)
Female
Pathogens
Research Article
Adult
030106 microbiology
Mycology
Research and Analysis Methods
Sensitivity and Specificity
Microbiology
03 medical and health sciences
Galactomannan
In vivo
Diagnostic Medicine
Nitriles
medicine
Humans
Acetonitrile
Molecular Biology Techniques
Microbial Pathogens
Molecular Biology
Formic Acid
Organic Chemistry
lcsh:R
Organisms
Fungi
Chemical Compounds
Correction
Biology and Life Sciences
medicine.disease
biology.organism_classification
Molds (Fungi)
chemistry
Immunoassay
lcsh:Q
Acids
Biomarkers
Zdroj: PLoS ONE, Vol 11, Iss 3, p e0151260 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: Invasive aspergillosis (IA) is a life-threatening systemic mycosis caused primarily by Aspergillus fumigatus. Early diagnosis of IA is based, in part, on an immunoassay for circulating fungal cell wall carbohydrate, galactomannan (GM). However, a wide range of sensitivity and specificity rates have been reported for the GM test across various patient populations. To obtain iron in vivo, A. fumigatus secretes the siderophore, N,N',N"-triacetylfusarinine C (TAFC) and we hypothesize that TAFC may represent a possible biomarker for early detection of IA. We developed an ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for TAFC analysis from serum, and measured TAFC in serum samples collected from patients at risk for IA. The method showed lower and upper limits of quantitation (LOQ) of 5 ng/ml and 750 ng/ml, respectively, and complete TAFC recovery from spiked serum. As proof of concept, we evaluated 76 serum samples from 58 patients with suspected IA that were investigated for the presence of GM. Fourteen serum samples obtained from 11 patients diagnosed with probable or proven IA were also analyzed for the presence of TAFC. Control sera (n = 16) were analyzed to establish a TAFC cut-off value (≥6 ng/ml). Of the 36 GM-positive samples (≥0.5 GM index) from suspected IA patients, TAFC was considered positive in 25 (69%). TAFC was also found in 28 additional GM-negative samples. TAFC was detected in 4 of the 14 samples (28%) from patients with proven/probable aspergillosis. Log-transformed TAFC and GM values from patients with proven/probable IA, healthy individuals and SLE patients showed a significant correlation with a Pearson r value of 0.77. In summary, we have developed a method for the detection of TAFC in serum that revealed this fungal product in the sera of patients at risk for invasive aspergillosis. A prospective study is warranted to determine whether this method provides improved early detection of IA.
Databáze: OpenAIRE